PLSE Operating Cash Flow (Statement)
Pulse Biosciences Inc · Operating Cash Flow (Statement)
PLSE Operating Cash Flow (Statement)
Latest reported-$18.71Mperiod ending
PLSE Quarterly Cash from Operations (-$174.18K → -$18.71M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
PLSE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -18,709,000 | |
| -14,595,000 | |
| -14,755,000 | |
| -13,039,000 | |
| -12,807,000 | |
| -13,521,000 | |
| -9,144,000 | |
| -9,024,000 | |
| -8,395,000 | |
| -9,780,000 | |
| -6,776,000 | |
| -10,487,000 | |
| -9,202,000 | |
| -6,570,000 | |
| -7,965,000 | |
| -10,632,000 | |
| -12,822,000 | |
| -15,594,000 | |
| -12,694,000 | |
| -13,350,000 | |
| -16,366,000 | |
| -11,687,000 | |
| -9,255,000 | |
| -8,549,000 | |
| -7,939,000 | |
| -9,622,000 | |
| -9,196,000 | |
| -7,965,000 | |
| -9,694,000 | |
| -7,330,000 | |
| -6,308,000 | |
| -6,850,000 | |
| -5,720,000 | |
| -5,018,000 | |
| -3,963,000 | |
| -3,417,000 | |
| -1,208,000 | |
| -2,499,000 | |
| -2,318,000 | |
| -1,982,000 | |
| -2,289,000 | |
| -1,462,000 | |
| -1,329,768 | |
| -948,000 | |
| -582,000 | |
| -457,000 | |
| -174,177 |